• Mabthera.co.nz
  • Roche.co.nz
  • Contact
  • Site Map
  • Text Size
Mabthera logo

MabThera® (rituximab) is a Prescription Medicine used to treat non-Hodgkin’s lymphoma and chronic lymphocytic leukaemia (types of blood cancer). MabThera should not be used if you have had an allergic reaction to MabThera, proteins of mouse origin or any of the ingredients listed on the medicine pack. Tell your doctor if you are pregnant or breastfeeding; or have had any immunisation recently; or are allergic to any other medicines, foods, dyes or preservatives; or have any other health problems including: heart disease, certain blood disorders (e.g. low white blood cells or platelets), hepatitis B or lung disease. Possible unwanted effects include: Common (during the infusion or a few hours afterward): fever, chills and severe shivering; nausea; fatigue; headache; runny nose; pain at the tumour site; skin rash or itchiness; shortness of breath; swelling of the face, lips, mouth, tongue or throat; drop in blood pressure; flushing; pain at site of infusion. Common (at any time): dizziness; insomnia, agitation, or anxiety; anaemia; pain in stomach, chest, back or neck; aching, weak, tender or stiff muscles; painful or swollen joints; indigestion, constipation or diarrhoea; difficulty swallowing; loss of appetite or weight loss; cough; sweating or night sweats; tingling, numbness or decreased sensitivity of the hands or feet; bleeding or bruising more easily; high blood sugar; high blood pressure; fast or irregular heart beat; throat irritation or mouth ulcers; watery or itchy eyes; pain or buzzing/ringing in the ears; infections. Rare (serious): severe skin rash, itching, hives; severe swelling of the face, lips, mouth, throat, hands, feet or ankles; severe shortness of breath, difficulty breathing, wheezing or coughing; frequent infections; numbness of the face; severe vision or hearing loss; vision loss with headaches; confusion and seizures; problems thinking or memory loss; changes in the way you move, walk or talk; decreased strength or weakness; severe stomach pain, nausea or vomiting, yellowing of skin and eyes, light coloured bowel motions, dark coloured urine. Ask your doctor if MabThera is right for you. Use strictly as directed. If symptoms continue or you experience side effects or would like further information please talk to your doctor or pharmacist or visit www.medsafe.govt.nz for MabThera Consumer Medicines Information. MabThera (100 mg/10 mL and 500 mg/50 mL single use vials) is a funded medicine under Special Authority for patients who meet pre-defined criteria. A prescription charge and normal doctor’s fees may apply. Consumer panel based on CMI dated 14 June 2011. Roche Products (New Zealand) Limited, Auckland. Ph 0800 656 464. www.roche.co.nz. All trademarks mentioned herein are protected by law.

For more information please view the MabThera Consumer Medicine Information. Access to this site is subject to the terms in our Legal Statement; you accept these terms by continuing to access this site. ID989/DA4011BR/2011JUN


This website was last updated on 09 May 2011. © 2011 Roche Products (New Zealand) Ltd.